The CDC's National Center of Immunization and Respiratory Diseases (NCIRD) developed and maintains the CVX (vaccine administered) code set. The table below has the most up to date values. It includes both active and inactive vaccines available in the US. CVX codes for inactive vaccines allow transmission of historical immunization records. Vaccine administered code set PyOBO v0.12.13-dev-207b46e9 on 2025-10-31T15:17:18.599702 by https://github.com/biopragmatics/pyobo/blob/main/src/pyobo/sources/cvx.py https://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx https://www2.cdc.gov/TemplatePackage/4.0/assets/imgs/logo/logo-notext.svg acronym has status false Inactive DTP diphtheria, tetanus toxoids and pertussis vaccine false DTP false Inactive OPV, trivalent This is the OPV used in the US from June 1963 through Dec 1999 and globally through April 2016 trivalent poliovirus vaccine, live, oral false false Active MMR measles, mumps and rubella virus vaccine false MMR false Inactive M/R measles and rubella virus vaccine false false Inactive measles virus vaccine false false Inactive rubella virus vaccine false false Inactive mumps virus vaccine false false Active Hep B, adolescent or pediatric This code applies to any standard pediatric formulation of Hepatitis B vaccine. It should not be used for the 2-dose hepatitis B schedule for adolescents (11-15 year olds). Use code 43 for that vaccine. hepatitis B vaccine, pediatric or pediatric/adolescent dosage false false Active Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) false false Active IPV poliovirus vaccine, inactivated false IPV false Inactive pneumococcal conjugate PCV 7 pneumococcal conjugate vaccine, 7 valent false false Active typhoid, ViCPs typhoid Vi capsular polysaccharide vaccine false false Non-US DTP-Hib-Hep B This CVX has been corrected. This non-US vaccine contained DTP, Hib and Hep B. It was withdrawn in 2007 . DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine false false Inactive meningococcal C conjugate vaccine false false Active Hep A-Hep B hepatitis A and hepatitis B vaccine false false Inactive vaccinia (smallpox) diluted vaccinia (smallpox) vaccine, diluted false false Active DTaP, 5 pertussis antigens diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens false false Inactive DTaP, unspecified formulation This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a DTaP vaccination when noted on a vaccination card) diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation false false Inactive meningococcal ACWY, unspecified formulation This CVX is intended for use when one of the meningococcal vaccines containing serogroups A, C, W and Y (conjugate or polysaccaride) was given and the exact formulation was not recorded. It should not be used to record newly administered immunizations. It is not to be used when one of the meningococcal vaccines containing other serogroups was administered. meningococcal ACWY vaccine, unspecified formulation false false Inactive pneumococcal, unspecified formulation This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a pneumococcal vaccination when noted on a vaccination card) pneumococcal vaccine, unspecified formulation false false Inactive pertussis vaccine false false Active DTaP-Hep B-IPV DTaP-hepatitis B and poliovirus vaccine false false Active Influenza, live, trivalent, intranasal, PF HCP administered, trivalent code reactivated for 2024/2025 season Influenza, live, trivalent, intranasal, preservative free false false Inactive tetanus toxoid, unspecified formulation false false Active Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) false false Active meningococcal MCV4P meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) false false Active Tdap tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed false false Active rotavirus, pentavalent rotavirus, live, pentavalent vaccine false true Never Active VZIG (IND) varicella zoster immune globulin (Investigational New Drug) false false Inactive HPV, bivalent human papilloma virus vaccine, bivalent false false Active rotavirus, monovalent rotavirus, live, monovalent vaccine false true Active diphtheria antitoxin false false Active DTaP-Hib-IPV diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) false false Inactive zoster live Zostavax vaccine associated to this CVX Code retired 10/2022 zoster vaccine, live false false Inactive rotavirus, unspecified formulation rotavirus vaccine, unspecified formulation false false Inactive influenza, H5N1-1203 influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) false false Inactive Novel Influenza-H1N1-09, nasal Novel Influenza-H1N1-09, live virus for nasal administration false false Inactive Novel influenza-H1N1-09, preservative-free Novel influenza-H1N1-09, preservative-free, injectable false false Inactive Novel influenza-H1N1-09 Novel influenza-H1N1-09, injectable false false Inactive This code is used whenever the actual formulation is not determined or when aggregating all Novel H1N1 Influenza-09 immunizations for reporting to CRA. It should not be used for seasonal influenza vaccine that is not otherwise specified. (NOS) Novel influenza-H1N1-09, all formulations false false Inactive Japanese Encephalitis, unspecified formulation This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a JE vaccination when noted on a vaccination card) Japanese Encephalitis vaccine, unspecified formulation false true Active TIG tetanus immune globulin false TIG false Active DTaP-IPV Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated false false Inactive typhus, historical Historical record of a typhus vaccination false false Inactive DTaP-IPV-HIB-HEP B, historical This is not the same as CVX 146, Hexavalent vaccine. Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine. false false Active Pneumococcal conjugate PCV 13 pneumococcal conjugate vaccine, 13 valent false false Active Japanese Encephalitis IM Japanese Encephalitis vaccine for intramuscular administration false false Active Influenza, high-dose, trivalent, PF Trivalent code reactivated for 2024/2025 season Influenza, high-dose, split virus, trivalent, injectable, preservative free false false Active Meningococcal MCV4O meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) false false Inactive This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a HPV vaccination when noted on a vaccination card) HPV, unspecified formulation false false Inactive Td (adult) Note that this Td is not adsorbed. tetanus and diphtheria toxoids, not adsorbed, for adult use false false Inactive This CVX code allows reporting of a historic vaccination when the formulation is unknown (for example, when recording a Td vaccination when noted on a vaccination card) Td(adult) unspecified formulation false true Inactive IG, unspecified formulation immune globulin, unspecified formulation false false Active Influenza, split virus, trivalent, PF Trivalent code reactivated for 2024/2025 season Influenza, split virus, trivalent, injectable, preservative free false false Active Influenza, split virus, trivalent, preservative Trivalent code reactivated for 2024/2025 season Influenza, split virus, trivalent, injectable, contains preservative false false Inactive tetanus toxoid, not adsorbed false false Active Adenovirus types 4 and 7 This vaccine is administered as 2 tablets. Adenovirus, type 4 and type 7, live, oral false false Inactive influenza, seasonal, intradermal, preservative free IIV3. No US product available since 2014/2015 flu season seasonal influenza, intradermal, preservative free false true Never Active RSV-MAb (new) respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular false false Active DTaP,IPV,Hib,HepB This vaccine is different from CVX 132. Code may be used to document non-US vaccines (e.g. Hexamin) of the same component formulation Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. false false Inactive meningococcal MCV4, unspecified formulation This CVX should only be used for historical doses of meningococcal conjugate vaccine where the formulation is unknown (oligosaccharide vs polysaccharide). It is not the same as CVX 108, Meningococcal, unspecified formulation. This CVX is for unspecified Meningococcal conjugate vaccines. Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135) false false Inactive Meningococcal C/Y-HIB PRP Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine false false Active Quadrivalent code starting 2013/2014 season Influenza, live, quadrivalent, intranasal false false Inactive influenza, split (incl. purified surface antigen) This code is being retired. It will still be found in older immunization records. It included both preservative free and non-preservative free. influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE true false Active Influenza, split virus, quadrivalent, PF Quadrivalent code starting 2013/2014 season Influenza, split virus, quadrivalent, injectable, preservative free false false Inactive This CVX should only be used for historical records where the formulation of nasal flu vaccine is not known. influenza nasal, unspecified formulation false false Inactive This CVX should only be used for historical records where the formulation of pneumococcal conjugate vaccine is not known. Pneumococcal Conjugate, unspecified formulation false false Active Influenza, MDCK, trivalent, PF Trivalent code reactivated for 2024/2025 season Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, preservative free false true Never Active Hep A, IG Do not use this code. This product may be used for Hep A and other viral infections. The correct vaccine / CVX is 86 (IG). Hepatitis A immune globulin true false Active Influenza, recombinant, trivalent, PF Trivalent code reactivated for 2024/2025 season Influenza, recombinant, trivalent, injectable, preservative free false true Active Rho(D)-IG This immune globulin may be administered either IM or IV. Rho(D) Immune globulin- IV or IM false true Active Rho(D) -IG IM This immune globulin may be administered IM only. Rho(D) Immune globulin - IM false false Active Influenza, split virus, quadrivalent, preservative Quadrivalent code starting 2013/2014 season Influenza, split virus, quadrivalent, injectable, contains preservative false true Inactive Rho(D) - Unspecified formulation Rho(D) Unspecified formulation false false Inactive influenza, whole influenza virus vaccine, whole virus false false Active Influenza A monovalent (H5N1), ADJUVANTED-2013 Approved by FDA 2013, adjuvant is mixed at point of administration. Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 false false Active Influenza, injectable,quadrivalent, preservative free, pediatric false false Active meningococcal B, recombinant meningococcal B vaccine, fully recombinant false false Active meningococcal B, OMV meningococcal B vaccine, recombinant, OMV, adjuvanted false false Inactive meningococcal B, unspecified meningococcal B, unspecified formulation false false Active HPV9 Human Papillomavirus 9-valent vaccine false false Inactive influenza, intradermal, quadrivalent, preservative free No US product available since 2017/2018 flu season influenza, intradermal, quadrivalent, preservative free, injectable false false Inactive meningococcal, unknown serogroups This CVX is intended for use when any one of the meningococcal vaccines is recorded and there is no information about which serogroups are protected against. This code should not be used when a newly administered immunization is recorded. meningococcal vaccine of unknown formulation and unknown serogroups false false Active Influenza, adjuvanted, trivalent, PF Trivalent code reactivated for 2024/2025 season Influenza, adjuvanted, inactivated, trivalent, injectable, preservative free false false Non-US Hep A, live attenuated This vaccine is not available in the US. Hep A, live attenuated-IM false false Inactive Hib, unspecified formulation Haemophilus influenzae type b vaccine, conjugate unspecified formulation false false Non-US DTAP/IPV/HIB - non-US This CVX was split off from CVX 102, to correctly identify the contents of the vaccine. non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) false false Active Influenza, MDCK, quadrivalent, PF Quadrivalent code starting 2016/2017 season Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, preservative free false false Non-US cholera, WC-rBS false false Non-US cholera, BivWC false false Active cholera, live attenuated false false Active Rabies - IM Diploid cell culture Human Rabies vaccine from human diploid cell culture false false Active Rabies - IM fibroblast culture Human rabies vaccine from Chicken fibroblast culture false false Non-US PCV10 This is a foreign vaccine pneumococcal conjugate vaccine, 10 valent false false Non-US OPV bivalent This is a non-US vaccine that may be seen in some immunization histories. Non-US bivalent oral polio vaccine (types 1 and 3) false false Non-US OPV ,monovalent, unspecified This is a non-US vaccine that may be seen in some immunization histories. It is composed of either Type 1, Type 2 or Type 3 oral polio vaccine. Non-US monovalent oral polio vaccine, unspecified formulation false false Inactive rabies, intramuscular injection This CVX code has been retired. It is replace by CVX 175, or CVX 176. It will continue to be found in historic records. rabies vaccine, for intramuscular injection RETIRED CODE false true Inactive This record duplicates CVX 13 (TIG). Do not use CVX 180. tetanus immune globulin true true Active anthrax immune globulin false false Inactive OPV, Unspecified This code represents an oral polio vaccine where the specific formulation is unknown. Oral Polio Vaccine, Unspecified formulation false false Active Yellow fever vaccine live - alt This CVX is associated to an FDA unapproved drug to be used when there is a drug shortage. Stabilized with sorbitol and lactose and has been used outside the US for some time. Yellow fever vaccine live - alternative formulation for vaccine shortage false false Inactive Yellow fever, unspecified Yellow fever vaccine, unspecified formulation false false Active Influenza, recombinant, quadrivalent, PF Quadrivalent code starting 2017/2018 season Influenza, recombinant, quadrivalent, injectable, preservative free false false Active Influenza, MDCK, quadrivalent, preservative Quadrivalent code starting 2017/2018 season Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, contains preservative false false Active zoster vaccine recombinant false false Inactive zoster, unspecified formulation This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a zoster vaccination when noted on a vaccination card) zoster vaccine, unspecified formulation false false Active HepB-CpG Hepatitis B vaccine (recombinant), CpG adjuvanted false false Active BCG Bacillus Calmette-Guerin vaccine false BCG false Non-US Typhoid conjugate vaccine (TCV) Typhoid conjugate vaccine (non-US) false false Non-US meningococcal A polysaccharide vaccine (non-US) false false Non-US meningococcal AC polysaccharide vaccine (non-US) false false Non-US Hep A-Hep B, pediatric/adolescent e.g. Twinrix Junior available in Canada hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US) false false Inactive Influenza, Southern Hemisphere This CVX code should be used to record administration of Southern Hemisphere influenza vaccine where formulation is unknown influenza, Southern Hemisphere, unspecified formulation false false Non-US DT, IPV adsorbed This code should be used to document non-US vaccines for DT,IPV such as Revaxis Diphtheria, Tetanus, Poliomyelitis adsorbed false false Active Td, adsorbed, preservative free, adult use, Lf unspecified Used when Td Lf specification is unknown tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified false false Active Influenza, high-dose, quadrivalent, PF Quadrivalent code starting season 2020/2021 Influenza, high-dose, split virus, quadrivalent, injectable, preservative free false false Non-US DTP-hepB-Hib Pentavalent Non-US This represents the non-US pentavalent vaccine. Should be used for historic documentation in US Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent) false false Active DTaP diphtheria, tetanus toxoids and acellular pertussis vaccine false false Active influenza, Southern Hemisphere, pediatric, preservative free Pediatric dose for ages 6-35 months influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free false false Active Influenza, Southern Hemisphere, quadrivalent, PF Represents single dose vial Influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5 mL dose, preservative free false false Active influenza, Southern Hemisphere, quadrivalent, with preservative Represents multi-dose vial influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative false false Active meningococcal conjugate quadrivalent, MenACWY-TT (MCV4) meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free false false Active FDA Approved ERVEBO Vaccine. Ebola Zaire vaccine, live, recombinant, 1mL dose false false Active Influenza, adjuvanted, quadrivalent, PF Quadrivalent code starting 2020/2021 season Influenza, adjuvanted, inactivated, quadrivalent, injectable, preservative free false false Active Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection Associated to FDA US Licensed product JYNNEOS, non-US tradenames IMVANEX, IMVAMUNE. Review CDC & FDA guidance for updates regarding administration Vaccinia, smallpox mpox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection false false Inactive COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose Original monovalent Moderna adult vaccine. FDA rescinded all doses for US use 4/18/2023. Continue to used to record historic US Moderna vaccines and those administered in non-US locations (includes tradename Spikevax) SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose false false Inactive COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose Original monovalent Pfizer adult vaccine (12+ yrs). FDA rescinded all doses for US use 4/18/2023. Continue to use to record historic US Pfizer vaccines and Non-US vaccines administered (includes tradename Comirnaty) SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose false false Active varicella virus vaccine false false Non-US COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL WHO authorized pandemic vaccine. Recognized towards immunity in US. AstraZeneca vaccine non-US WHO authorized tradenames/identifiers include VAXZEVRIA, AZD1222, ChAdOx1 nCoV-19, COVISHIELD SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL false false Inactive COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL Original monovalent Novavax vaccine (12+ years), FDA rescinded for US doses 10/03/2023. Continue to use to record Novavax Non-US vaccines administered (includes tradenames NUVAXOVID, COVOVAX) SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose false false Inactive COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL Original monovalent Janssen/J&J adult vaccine. All NDCs expired 6/20/2023, not reauthorized by FDA for Fall 2023 US doses. Continue to use to record Jansses/J&J Non-US vaccines administered vaccines administered SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL false false Inactive Unspecified code for COVID-19 not to be used to record patient US administration. May be used to record historic US administration if product not known. CVX code 500 should be used to record Non-US vaccine where product is not known. SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED false false Inactive Ebola, unspecified false false Active Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free false false Active Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free false false Inactive COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose Original monovalent Pfizer tris-sucrose formulation FDA EUA (12+ yrs) and BLA (16+ yrs), FDA rescinded monovalent use 08/31/2022, BLA NDCs not retired until 09/11/2023. SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation false false Inactive COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose Original monovalent Pfizer tris-sucrose formulation (5 yrs through 11 yrs), FDA rescinded 4/18/2023 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation false false Inactive COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose Original monovalent Pfizer tris-sucrose formulation (6 mo through 4 yrs), FDA rescinded 4/18/2023 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation false false Inactive DTP-Hib DTP-Haemophilus influenzae type b conjugate vaccine false false Inactive HepB recombinant, 3-antigen, Al(OH)3 Manufacturer VBI has ceased operations - Prehevbrio Hep B vaccine voluntary recall effective 11/15/2024 Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvanted false false Inactive COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose Original monovalent Moderna, (Adult) FDA rescinded 4/18/2023, (6 yrs through 11 yrs) FDA rescinded 04/18/2023 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose false false Inactive Tick-borne encephalitis, unspecified Unspecified Code - should only be used when specific vaccine administered is unknown Tick-borne encephalitis vaccine, unspecified false false Active Tick-borne encephalitis, inactivated, PF, 0.25mL Pediatric dose vaccine Tick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose false false Active Tick-borne encephalitis, inactivated, PF, 0.5mL Adult dose vaccine Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose false false Never Active COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL EUA submission withdrawn by Sanofi SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 5mcg/0.5mL dose false false Never Active COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL EUA submission withdrawn by Sanofi SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 10mcg/0.5mL dose false false Inactive COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose Original monovalent Moderna pediatric vaccine (FDA rescinded 4/18/2023). Inactivated 6/14/2022 to use CVX code 221 product instead SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose false false Inactive COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose Original monovalent Moderna pediatric vaccine (6 mo through 5 yrs), FDA rescinded 4/18/2023 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose false false Inactive COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose Original strain + omicron BA.4/BA.5 bivalent Moderna vaccine (6 mo and older), FDA rescinded 9/11/2023. Continue to use to record Non-US vaccines administered (tradename Spikevax Bivalent) SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose false false Inactive plague vaccine false false Inactive COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL Original strain + omicron BA.4/BA.5 bivalent Moderna vaccine (6 mo through 5 yrs), FDA rescinded 9/11/2023 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose false false Active influenza, Southern Hemisphere, high-dose, quadrivalent Target population 65 and older, starting Southern Hemisphere season 2023 influenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free false false Active Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis Anthrax vaccine, adsorbed, pre-exposure and post-exposure prophylaxis false false Active typhoid, oral typhoid vaccine, live, oral false false Inactive cholera, unspecified formulation cholera vaccine, unspecified formulation false true Active botulinum antitoxin false false Inactive DT (pediatric) Retired effective 04/30/2023. All vaccine NDCs retired. No further vaccines expected for this formulation. diphtheria and tetanus toxoids, adsorbed for pediatric use false true Active CMVIG cytomegalovirus immune globulin, intravenous false CMVIG true Active HBIG hepatitis B immune globulin false HBIG false Inactive COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose Original strain + omicron BA.4/BA.5 bivalent Pfizer vaccine (12 yrs and older). FDA rescinded 09/11/2023. Continue to use to record Non-US vaccines administered (tradename Comirnaty Bivalent) SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation false false Inactive COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose Original strain + omicron BA.4/BA.5 bivalent Pfizer vaccine (5 yrs through 11 yrs), FDA rescinded 9/11/2023 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation false false Inactive COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose Original strain + omicron BA.4/BA.5 bivalent Pfizer vaccine (6 mo through 4 yrs), FDA rescinded 09/11/2023 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation false false Active RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF Adults 60 years and older Respiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free false false Inactive Unspecified, for historic records where it is not known if RSV vaccine or RSV MAB was administered Respiratory syncytial virus (RSV), unspecified false false Active RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF Adults 60 years and older, pregnant individuals Respiratory syncytial virus (RSV), vaccine, bivalent, protein subunit RSV prefusion F, diluent reconstituted, 0.5 mL, preservative free false false Active RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months RSV monoclonal antibody (Beyfortus) Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 0.5 mL, neonates and children to 24 months false false Active RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months RSV monoclonal antibody (Beyfortus) Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 1 mL, neonates and children to 24 months false false Inactive COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL EUA Revoked 08/27/2024. Pfizer 6 months through 4 years of age. SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL dose false false Active COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL Pfizer Fall Seasonal 12 years and older SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose false false Inactive Hep A, pediatric, unspecified formulation Do NOT use this code. If formulation is unknown, use CVX 85. There is only one formulation of Hep A, peds. hepatitis A vaccine, pediatric dosage, unspecified formulation true false Active COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL Pfizer Fall Seasonal 5 years through 11 years of age SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose false false Active COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL Moderna Fall Seasonal 6 months through 11 years of age SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose false false Active COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL Moderna Fall Seasonal 12 years and older SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose false false Active COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL Novavax Fall Seasonal 12 years and older SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 5 mcg/0.5 mL dose false false Inactive Unspecified, for historic records where the specific vaccine administered is not known Respiratory syncytial virus (RSV) vaccine, unspecified false false Inactive Respiratory syncytial virus (RSV) MAB, unspecified Unspecified, for historic records where the specific RSV MAB administered is not known Respiratory syncytial virus (RSV) monoclonal antibody (MAB), unspecified false false Active Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF Meningococcal pentavalent vaccine strains ABCW and Y Meningococcal polysaccharide (groups A, C, Y, W) tetanus toxoid conjugate, meningococcal B recombinant vaccine, 0.5mL, preservative free false false Active Chikungunya live attenuated vaccine, 0.5 mL, PF Chikungunya Vaccine Chikungunya, live attenuated vaccine, 0.5 mL, preservative free false false Active Anthrax, post-exposure prophylaxis National stockpile vaccine (Cyfendus) Anthrax vaccine, adsorbed, adjuvanted, post-exposure prophylaxis false false Inactive Unspecified code to record historic administration when specific product is unknown Anthrax vaccine, unspecified false false Inactive meningococcal MPSV4 meningococcal polysaccharide vaccine (MPSV4) false false Active Influenza, MDCK, trivalent, preservative Trivalent code starting 2024/2025 season Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, contains preservative false false Active Influenza-avian, H5N8, monovalent, PF Novel Bird Flu H5N8 Vaccine 2024 Influenza-avian, H5N8, viral-vector, monovalent, injectable, preservative free false false Active Influenza-avian, H5N8, monovalent, preservative Novel Bird Flu H5N8 Vaccine 2024 Influenza-avian, H5N8, viral-vector, monovalent, injectable, contains preservative false false Inactive Unspecified code H5xx vaccines to be used when specific formulation is unknown - for vaccines administered starting 2024 Influenza-avian, H5, unspecified formulation false false Non-US Non-US polio vaccine administered since 2016 Poliovirus, inactivated, fractional-dose (fIPV) false false Inactive Use this CVX for historical records where; the formulation administered is not known, or is a non-US product without an associated CVX code. Vaccinia (smallpox, mpox), unspecified false false Active RSV, mRNA, injectable, PF mRNA RSV vaccine added 2024 Respiratory syncytial virus (RSV), mRNA, injectable, preservative free false false Active Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF Pneumococcal conjugate vaccine, 21 valent (PCV21), polysaccharide CRM197 conjugate, preservative free false false Active Meningococcal oligosaccharide (MenACWY), (MenB), PF Meningococcal pentavalent vaccine strains ABCW and Y Meningococcal oligosaccharide conjugated (groups A, C, W, Y) and group B, 0.5 mL, preservative free false false Active Chikungunya, VLP, recombinant, 0.8 mL, PF Chikungunya, virus-like particle (VLP), recombinant vaccine, 0.8 mL, preservative free false false Active pneumococcal polysaccharide PPV23 pneumococcal polysaccharide vaccine, 23 valent false false Inactive Dengue fever, unspecified Use this CVX for historical records where; the formulation of the dengue vaccine administered is not known, or is a non-US product without an associated CVX code. Dengue fever, unspecified formulation false false Active Influenza, Southern Hemisphere, trivalent, PF Represents single dose vial Influenza, seasonal, Southern Hemisphere, trivalent, 0.5 mL dose, preservative free false false Active RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF RSV mAb for neonates and infants born during or entering first RSV season (Enflonsia) Respiratory syncytial virus (RSV), monoclonal antibody, IgG1κ, (clesrovimab-cfor), 0.7 mL, neonate and infant, preservative free false false Active Influenza, live, trivalent, intranasal, self/caregiver admin, PF Self or caregiver administered, new starting 2025/2026 season Influenza, live, trivalent, intranasal, self or caregiver administered, preservative free false false Active COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL Moderna monovalent new formulation mNEXSPIKE, starting Fall 2025, ages 12 yrs and older, BLA SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2 mL dose false true Active RIG rabies immune globulin false RIG false Inactive tetanus toxoid, adsorbed false true Active VZIG varicella zoster immune globulin false VZIG false Active This is the YF vaccine that has been available in the US for years. It is stabilized with sorbitol and gelatin. yellow fever vaccine live false false Inactive rubella/mumps rubella and mumps virus vaccine false false Inactive Japanese Encephalitis Vaccine SC false false Inactive rabies, intradermal injection rabies vaccine, for intradermal injection false false Inactive typhoid, parenteral typhoid vaccine, parenteral, other than acetone-killed, dried false false Inactive Hep B, adolescent/high risk infant As of August 27, 1998, Merck ceased distribution of their adolescent/high risk infant hepatitis B vaccine dosage. Code 42 should only be used to record historical records. For current administration of hepatitis B vaccine, pediatric/adolescent dosage, use code 08. hepatitis B vaccine, adolescent/high risk infant dosage false false Active Hep B, adult This code applies to any standard adult dose and schedule. Also use CVX 43 for the FDA approved Recombivax HB 2-dose hepatitis B schedule for adolescents (11-15 year olds) using the adult formulation. hepatitis B vaccine, adult dosage false false Active Hep B, high-dosage, dialysis or IC This code is used record patient high dosage vaccine administration for dialysis or immunocompromised patients. For NDCs that are used for both regular vaccine and dialysis/IC high-dosage schedules (e.g. Engerix-B), are mapped to both CVX 43 and CVX 44. CVX code 44 should be utilized to record dialysis/IC dosing. Hepatitis B vaccine (Hep B), high-dosage, dialysis or immunocompromised patient false false Inactive Hep B, unspecified formulation This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a HepB vaccination when noted on a vaccination card) hepatitis B vaccine, unspecified formulation false false Inactive Hib (PRP-D) Haemophilus influenzae type b vaccine, PRP-D conjugate false false Inactive Hib (HbOC) Haemophilus influenzae type b vaccine, HbOC conjugate false false Active Hib (PRP-T) Haemophilus influenzae type b vaccine, PRP-T conjugate false false Active Hib (PRP-OMP) Haemophilus influenzae type b vaccine, PRP-OMP conjugate false false Inactive DTaP-Hib DTaP-Haemophilus influenzae type b conjugate vaccine false false Non-US COVID-19 Non-US Vaccine, UNSPECIFIED Unspecified code to be used to record historic Non-US COVID-19 administration. May be used if the specific product or CVX code is not known. SARS-COV-2 (COVID-19) Non-US Vaccine, UNSPECIFIED false false Non-US COVID-19 IV Non-US Vaccine (QAZCOVID-IN) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN) false false Non-US COVID-19 IV Non-US Vaccine (COVAXIN) Pandemic Non-US Vaccine Authorized by WHO 11-3-2021, recognized toward immunity in US, https://extranet.who.int/pqweb/vaccines/who-recommendation-bharat-biotech-international-ltd-covid-19-vaccine-whole-virion SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN) false false Non-US COVID-19 LAV Non-US Vaccine (COVIVAC) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC) false false Non-US COVID-19 VVnr Non-US Vaccine (Sputnik Light) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light) false false Non-US COVID-19 VVnr Non-US Vaccine (Sputnik V) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V) false false Non-US COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology Pandemic Non-US Vaccine. Authorized by WHO 5/19/2022 - Counted toward immunity in US SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology false false Non-US COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences) false false Non-US COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention) false false Non-US COVID-19 PS Non-US Vaccine (EpiVacCorona) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona) false false Inactive Hib-Hep B This vaccine may still be in use until the existing lots expire on 8/19/16. Haemophilus influenzae type b conjugate and Hepatitis B vaccine false false Non-US COVID-19 IV Non-US Vaccine (BIBP, Sinopharm) Pandemic Non-US Vaccine. Authorized by WHO - Counted toward immunity in US SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm) false false Non-US COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) Pandemic Non-US Vaccine. Authorized by WHO - Counted toward immunity in US SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac) false false Non-US SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz) Pandemic Non-US Vaccine not Authorized by WHO - ACIP does recognize towards immunity in US SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz) false false Non-US SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax) false false Non-US SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D) false false Non-US SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901) false false Non-US COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) false false Non-US SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax) false false Non-US COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) false false Non-US COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna Pandemic Non-US Vaccine not Authorized by WHO - Is authorized by EU and counted toward immunity in US SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna false false Active Hep A, adult hepatitis A vaccine, adult dosage false false Non-US COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech Pandemic Non-US Vaccine. Authorized by WHO 10/19/2022 - Counted toward immunity in US SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech false false Non-US COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US SARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK false false Inactive typhoid, parenteral, AKD (U.S. military) typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) false false Inactive adenovirus, type 4 adenovirus vaccine, type 4, live, oral false false Inactive adenovirus, type 7 adenovirus vaccine, type 7, live, oral false false Active dengue fever tetravalent Applies to tetravalent product (e.g. DENGVAXIA) dengue fever vaccine, tetravalent false false Never Active hantavirus hantavirus vaccine false false Never Active Hep C hepatitis C vaccine false false Never Active Hep E hepatitis E vaccine false false Never Active herpes simplex 2 herpes simplex virus, type 2 vaccine false false Never Active HIV human immunodeficiency virus vaccine false HIV false Active HPV, quadrivalent human papilloma virus vaccine, quadrivalent false false Never Active Junin virus Junin virus vaccine false false Never Active leishmaniasis vaccine false false Never Active leprosy vaccine false false Inactive Lyme disease vaccine false false Never Active malaria vaccine false false Never Active melanoma vaccine false false Inactive parainfluenza-3 virus vaccine false false Never Active Q fever vaccine false true Inactive RSV-IGIV No active NDCs or CPT codes associated to this CVX respiratory syncytial virus immune globulin, intravenous false false Never Active rheumatic fever vaccine false false Never Active Rift Valley fever vaccine false false Inactive rotavirus, tetravalent rotavirus, live, tetravalent vaccine false false Active Vaccinia (smallpox, mpox), live Vaccinia (smallpox, mpox) vaccine, live false true Inactive Staphylococcus bacterio lysate Staphylococcus bacteriophage lysate false false Non-US Non-US vaccine Tick-borne encephalitis vaccine (non-US) false false Inactive tularemia vaccine false true Active vaccinia immune globulin false false Inactive VEE, live Venezuelan equine encephalitis, live, attenuated false true Active This is the adjuvant that is packaged with H5N1 vaccine, adjuvanted AS03 Adjuvant false false Inactive VEE, inactivated Venezuelan equine encephalitis, inactivated false false Inactive adenovirus, unspecified formulation This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a adenovirus vaccination when noted on a vaccination card) adenovirus vaccine, unspecified formulation false false Active Hep A, ped/adol, 2 dose hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule false false Inactive Hep A, ped/adol, 3 dose This vaccine formulation is inactive and should not be used, except to record historic vaccinations with this formulation. hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule false false Inactive Hep A, unspecified formulation This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a HepA vaccination when noted on a vaccination card) hepatitis A vaccine, unspecified formulation false true Active IG immune globulin, intramuscular false IG true Active IGIV immune globulin, intravenous false IGIV false Inactive influenza, unspecified formulation This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a Influenza vaccination when noted on a vaccination card) influenza virus vaccine, unspecified formulation false false Inactive This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a polio vaccination when noted on a vaccination card) poliovirus vaccine, unspecified formulation false false Inactive rabies, unspecified formulation This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a rabies vaccination when noted on a vaccination card) rabies vaccine, unspecified formulation false false Inactive typhoid, unspecified formulation This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a typhoid vaccination when noted on a vaccination card) typhoid vaccine, unspecified formulation false false Inactive VEE, unspecified formulation This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a VEE vaccination when noted on a vaccination card) Venezuelan equine encephalitis vaccine, unspecified formulation false true Active RSV-MAb respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular false false Active MMRV measles, mumps, rubella, and varicella virus vaccine false MMRV true Inactive TST-OT tine test TB Skin test is not vaccine. tuberculin skin test; old tuberculin, multipuncture device false true Inactive TST-PPD intradermal TB Skin test is not vaccine. tuberculin skin test; purified protein derivative solution, intradermal false true Inactive TST-PPD tine test TB Skin test is not vaccine. tuberculin skin test; purified protein derivative, multipuncture device false true Inactive TST, unspecified formulation TB Skin test is not vaccine. tuberculin skin test; unspecified formulation false true Inactive Code 998 was added for use in VXU HL7 messages where the OBX segment is nested with the RXA segment, but the message does not contain information about a vaccine administration. An example of this use is to report the vaccines due next for a patient when no vaccine administration is being reported. no vaccine administered false true Inactive unknown This CVX code has little utility and should rarely be used. unknown vaccine or immune globulin false